Marketing Retarget Pixel

Timothy Gladwell

  • Timothy-Gladwell

    Timothy D. Gladwell, Pharm.D, BCPS, BCACP
    Interim Dean, School of Pharmacy and Health Professions
    Associate Dean for Academic Affairs and Assessment
    Associate Professor, Pharmacy Practice


    Education

    • Pharm.D. – University of Maryland School of Pharmacy (1996)
    • B.S. Chemistry – University of Maryland Eastern Shore (1992)

    Bio

    Dr. Gladwell is a native of the Eastern Shore of Maryland.  He received his Bachelor of Science in Chemistry from UMES and his Doctor of Pharmacy from the University of Maryland School of Pharmacy (UMSOP). After graduation from UMSOP, Dr. Gladwell completed a PGY-1 residency at Johns Hopkins Hospital followed by a PGY-2 residency in Internal Medicine and Cardiology at UMSOP. Prior to his current appointment, he served as a full-time faculty member at several different schools of pharmacy including Duquesne University in Pittsburgh, Pennsylvania, and Husson University in Bangor, Maine.  He was also a member of the faculty at the UMES School of Pharmacy during its inaugural years from 2010-2011, and he was involved in developing many of the current courses within the program.  

    As a registered pharmacist for over 20 years, Dr. Gladwell has practiced in a variety of settings.  He has served as a clinical specialist in Cardiology Critical Care in a large teaching hospital, he has worked as a pharmacy manager in several chain pharmacies on Delmarva, and he has developed pharmacist-run ambulatory clinics with collaborative practice agreements in a federally-qualified health center in Maine.  He is currently board certified in both Pharmacotherapy (BCPS) and Ambulatory Care (BCACP) by the Board of Pharmacy Specialties, and is a certified immunization trainer through the American Pharmacists Association (APhA).  Dr. Gladwell is a member of several pharmacy organizations including the American College of Clinical Pharmacy (ACCP) and the American Association of Colleges of Pharmacy (AACP), and he serves as the UMES faculty liaison to ACCP. His research interests include assessments of educational initiatives in a pharmacy curriculum as well as investigations of pharmacy practice models and the appropriate use of medications to improve the outcomes of patients with chronic diseases.  

    Dr. Gladwell has been recognized with multiple awards for his commitment to education and the practice of pharmacy, including the UMES School of Pharmacy and Health Professions Dean’s Award in 2017, the UMES School of Pharmacy SP-2 Faculty of the Year Award in 2016, the Husson University School of Pharmacy P4 Teacher of the Year Award in 2015, the Husson University School of Pharmacy P3 Teacher of the Year Award in 2014, the inaugural Duquesne University Mylan School of Pharmacy Excellence in Online Teaching Faculty Award in 2002, and the University of Maryland School of Pharmacy Smithkline Beecham Pharmaceuticals Award for Superior Achievement in Patient Care Award in 1998.

    During his off time, he enjoys traveling, reading, and spending time with his wife, Nancy Edgeworth, who is also a pharmacist.

    Courses Taught

    PHAR 612 PTMM: Cardiology

    PHAR 613 PTMM: Immunology/Rheumatology

    PHAR 624 Integration of Pharmacy Practice I

    PHAR 625 Integration of Pharmacy Practice II

    PHAR 795 Transition to the Profession I

     

    Scholarly Activities

       Publications

    • “Module 1: Introduction: Overview of Study Design” UAN #0202-0000-18-140-H04-P (0.15 CEU)

    • “Module 2: An overview of randomized control study design” UAN 0202-0000-18-141-H04-P (0.35 CEU)

    • “Module 3: An overview of meta-analysis design” UAN 0202-0000-18-142-H04-P (0.35 CEU)

    • “Module 4: An overview of observational study design” UAN 0202-0000-18-143-H04-P (0.35 CEU)

    • “Module 5: An overview on how to appraise practice guidelines” UAN 0202-0000-18-144-H04-P (0.35 CEU)

    • Gladwell T and Williams E. Ten pitfalls to avoid when evaluating the primary literature.  iForumRx.org. January 2017.  Available at: http://iforumrx.org/node/360.
    • Gladwell TD. Blood pressure control and diabetes: what should our goal be ACCORDing to the evidence?  iForumRx.org. May 2011.  Available at: http://iforumrx.org/index.php?q=node/61
    • Gladwell TD. Bivalirudin: a direct thrombin inhibitor. Clin Ther 2002;24:38-58. PMID: 11833835.
    • Gladwell TD. New guidelines for treatment of hyperlipidemia and their impact on patient care in a community pharmacy. Drug Store News Continuing Education Quarterly  Oct – Dec 2001:pp39-45.
    • Gottlieb SS, Skettino SL, Wolff A, Beckman E, Fisher ML, Freudenberger R, Gladwell T, Marshall J, Cines M, Bennett B, Littschwager EB. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure. J Am Coll Cardiol 2000;35:56-9. PMID: 10636259.
    • Gladwell TD. Asthma drug therapy. Clin Trends Pharm Practice 1998;12(1):1-12. Universal Program #332-000-98-001-H01 (0.2 CEU)
    • Pou S, Ramos CL, Gladwell T, Renks E, Centra M, Young D, et al. A kinetic approach to the selection of a sensitive spin trapping system for the detection of hydroxyl radical. Anal Biochem 1994;217:76-83. PMID: 7766670.
    • Pou S, Nguyen SY, Gladwell T, Rosen GM. Does peroxynitrite generate hydroxyl radical? Biochimica et Biophysica Acta 1995;1244:62-8. PMID: 8203741.

    Poster Presentations

    • Gladwell T, Truong H, Fasanella DR, Hogue GL, DeBenedetto RA, Sherr L, et al. “Implementation of a Multi-Faceted Approach to Assess Student Achievement of CAPE Domain 4 Learning Outcomes.” Presented at the 2018 AACP Annual Meeting, Nashville, TN, July 2017.
    • Gladwell TD, Webster KD. “Assessment of first-year pharmacy students’ attitudes and performance during a required immunization training program.” Presented at the 2011 AACP Annual Meeting, San Antonio, TX, July 2011.
    • Pavlik DJ, Hite MS, Gladwell TD. "Evaluation of warfarin utilization in a tertiary-care teaching hospital." Presented at the 35th Annual ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2000
    • Veltri MA, Glenn DJ, Gladwell T. "Development and implementation of a pharmacy-based, automatic dose standardization program for pediatrics." Presented at the 32nd Annual ASHP Midyear Clinical Meeting, Atlanta, GA, December 1997
    • Gladwell TD, Pou S.  "Study of peroxynitrite-mediated cellular damage." Presented at the Merck Undergraduate Research Symposium, AACP National Meeting, Philadelphia, PA, July 11, 1995

    Continuing Education Presentations

    • Gladwell TD. “Updates on the management of hypertension: a focus on the 2017 ACC/AHA guidelines.” Presented at the Delaware Pharmacists Society Annual Meeting, Newark, DE, May 9, 2018.
    • Gladwell TD. “Weighing the evidence: pharmacotherapy of obesity in adults.” Presented at the Delaware Pharmacists Society Annual Meeting, Dewey Beach, DE, May 10, 2017.
    • Gladwell TD. “Weighing the evidence: pharmacotherapy of obesity in adults.” ACPE #0798-9999-16-120-l01-P. Presented at the Eastern Shore Pharmaceutical Society meeting, Fruitland, MD, September 28, 2016.
    • Gladwell TD. “Weighing the evidence: pharmacotherapy of obesity in adults.” ACPE #0798-9999-16-120-L01-P. Presented at the Peninsula Regional Medical Center Pharmacy Grand Rounds, Salisbury, MD, August 19, 2016.
    • Gladwell TD. “From ASH/ISH to JNC8: making sense of the updated guidelines for the management of hypertension.” ACPE #0837-9999-15-024-L01-P/T. Presented at the Maine Pharmacy Association Spring 2015 Conference & Trade Show, Freeport, ME, March 21, 2015.
    • Gladwell TD. “Updates on the management of dyslipidemia: a review of the 2013 ACC/AHA cholesterol guidelines.” ACPE #0837-9999-15-023-L01-P/T. Presented at the Maine Pharmacy Association Spring 2015 Conference &Trade Show, Freeport, ME, March 21, 2015.
    • Gladwell TD. “Novel antithrombotic medications.” ACPE #0837-9999-14-086-L01-P/T. Presented at the Maine Pharmacy Association Fall 2014 Conference, Trade Show, and Awards Banquet, Bangor, ME, September 7, 2014.
    • Gladwell TD. “Updates on the management of dyslipidemia: a review of the 2013 ACC/AHA cholesterol guidelines.” ACPE #0837-9999-14-076-L01-P/T. Presented at the Maine Pharmacy Association Fall 2014 Conference, Trade Show, and Awards Banquet, Bangor, ME, September 6, 2014.
    • Gladwell TD. “From ASH/ISH to JNC8: making sense of the updated guidelines for the management of hypertension.” ACPE #0837-9999-14-077-L01-P/T. Presented at the Maine Pharmacy Association Fall 2014 Conference, Trade Show, and Awards Banquet, Bangor, ME, September 7, 2014.
    • Gladwell TD. “Hitting the target: individualizing drug therapy to achieve optimal outcomes in patients with type 2 diabetes.” Presented at the Husson Institute for Continuing Health Education Programming’s Clinical Pharmacotherapy Series, January 16, 2013.
    • Gladwell TD. “Medication therapy management: a primer for pharmacists.” Universal Program #0136-0000-11-007-L01-P (0.1 CEU)  Presented at the 125th Annual Delaware Pharmacists Society Convention, Rehoboth Beach, DE, May 25, 2011.
    • Gladwell TD. “Lipoprotein metabolism, atherosclerosis, and clinical outcomes: an evidence-based review.” Universal Program #055-000-01-037-L01 (0.1 CEU). Presented at the Duquesne University Mylan School of Pharmacy Dyslipidemia Pharmacist Disease Management Program, Pittsburgh, PA, November 9, 2001.
    • Gladwell TD. "Drug-induced QT interval prolongation." Presented at the Fourth Annual Physician Assistant Knowledge Update, Pittsburgh, PA, October 4, 2001.
    • Gladwell TD. "Combination therapies for ACS: GP IIb/IIIa inhibitors, thrombolytics, and low-molecular-weight heparins." Presented at the Third Annual Pharmacy Directors' Conference on Acute Coronary Syndromes, Pittsburgh, PA, February 24, 2001.
    • Gladwell TD. "An update on the use of glycoprotein IIb/IIIa receptor inhibitors in coronary artery disease."  Presented to the Three Rivers Chapter of the American Association of Critical Care Nurses, Warrendale, PA, October 23, 2000
    • Gladwell TD. "Asthma drug therapy" Universal Program #055-000-99-008-L01 (0.1 CEU) Presented to Duquesne University School of Pharmacy Alumni, Seven Springs, PA, May 1, 1999
    • Gladwell TD. "The use of low-molecular-weight heparins in unstable coronary artery disease."  Universal Program #025-000-97-031-L04  (0.1 CEU)  Presented to University of Maryland School of Pharmacy Residents and Preceptors, Baltimore, MD, October 23, 1997